39
59
Growth Score
-7 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
271315
CoSyne Therapeutics is a biotechnology company that uses polymathic AI for drug discovery and development, focusing on patient welfare.
- Michael Johnson: CMO and Co-Founder
- Louwai Muhammed: Chief Executive Officer and Co-Founder
About the Company
CoSyne Therapeutics operates in the biotechnology industry, focusing on drug discovery. The company utilizes polymathic AI to revolutionize the way medicines are discovered and developed. Their mission is to aid patients suffering from devastating diseases, prioritizing patient welfare above all else. CoSyne Therapeutics is also involved in the
field of Synthetic Lethality. They aim to identify novel therapeutic opportunities that traditional methods may not capture. The company also offers job opportunities in various roles such as Senior ML Researcher in Genomics and Lead ML Researcher in Chemistry AI.
